Renaissance Capital logo

T2 Biosystems Priced, Nasdaq: TTOO

Developing diagnostic tests to screen for sepsis and impaired hemostasis.

Industry: Health Care

First Day Return: +30.2%

Industry: Health Care

Developing diagnostic tests to screen for sepsis and impaired hemostasis.
more less
IPO Data
IPO File Date 07/02/2014
Offer Price $11.00
Price Range $15.00 - $17.00
Offer Shares (mm) 5.2
Deal Size ($mm) $57
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 08/06/2014
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $57
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Lexington, MA, United States
Founded 2006
Employees at IPO 68
Website www.t2biosystems.com

T2 Biosystems (TTOO) Performance